Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C477819 |
15-deoxyprostaglandin J2 |
15-deoxyprostaglandin J2 inhibits the reaction [25-hydroxycholesterol results in increased expression of CNN1 mRNA] | decreases reaction|increases expression | 17161435
|
C477819 |
15-deoxyprostaglandin J2 |
15-deoxyprostaglandin J2 inhibits the reaction [alitretinoin results in increased expression of CNN1 mRNA] | decreases reaction|increases expression | 17161435
|
C477819 |
15-deoxyprostaglandin J2 |
15-deoxyprostaglandin J2 results in decreased expression of CNN1 mRNA | decreases expression | 17161435
|
C007997 |
25-hydroxycholesterol |
15-deoxyprostaglandin J2 inhibits the reaction [25-hydroxycholesterol results in increased expression of CNN1 mRNA] | decreases reaction|increases expression | 17161435
|
C007997 |
25-hydroxycholesterol |
25-hydroxycholesterol results in increased expression of CNN1 mRNA | increases expression | 17161435
|
C007997 |
25-hydroxycholesterol |
alitretinoin promotes the reaction [25-hydroxycholesterol results in increased expression of CNN1 mRNA] | increases expression|increases reaction | 17161435
|
C103303 |
alitretinoin |
15-deoxyprostaglandin J2 inhibits the reaction [alitretinoin results in increased expression of CNN1 mRNA] | decreases reaction|increases expression | 17161435
|
C103303 |
alitretinoin |
alitretinoin promotes the reaction [25-hydroxycholesterol results in increased expression of CNN1 mRNA] | increases expression|increases reaction | 17161435
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of CNN1 mRNA | increases expression | 17161435
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of CNN1 protein | decreases expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CNN1 mRNA | increases expression | 20382639
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I results in decreased expression of CNN1 mRNA | decreases expression | 15380616
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I results in decreased expression of CNN1 protein | decreases expression | 15380616
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of CNN1 mRNA | increases expression | 18180321
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of CNN1 mRNA | increases expression | 17484886
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of CNN1 mRNA | increases expression | 18042831
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of CNN1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNN1 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CNN1 mRNA | increases expression | 12075121
|
C487498 |
Go 6983 |
Go 6983 results in decreased expression of CNN1 mRNA | decreases expression | 15380616
|
C487498 |
Go 6983 |
Go 6983 results in decreased expression of CNN1 protein | decreases expression | 15380616
|
C041786 |
palm oil |
palm oil results in increased expression of CNN1 mRNA | increases expression | 18042831
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of CNN1 mRNA | decreases expression | 12807726
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of CNN1 mRNA | increases expression | 18158353
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of CNN1 mRNA | increases expression | 17350061
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of CNN1 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CNN1 mRNA | increases expression | 11489354
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNN1 mRNA | affects cotreatment|increases expression | 17942748
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in decreased expression of CNN1 mRNA | decreases expression | 15380616
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in decreased expression of CNN1 protein | decreases expression | 15380616
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CNN1 mRNA | increases expression | 17069765
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of CNN1 mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.47 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
8.01 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.01 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.47 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.86 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.79 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
9.80 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.80 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.62 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.82 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.54 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.87 | 11748828 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.03 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
9.62 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
9.62 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.02 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.02 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.32 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.32 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.66 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.66 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.71 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.71 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.78 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.46 | 15306635 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.92 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.92 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.92 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.92 | 20544844 16202921 15668708 19103187 15565566 18855134 18629630 18425577 19155303 19142967 20135344 18984771 18351453 20005174 19115204 19289846 11161223 19189212 21138602 19221464 19244106 19066611 17261762 19189210 20390343 19288272 18997820 19200415 16873071 19410462 20859285 18821012 19059307 19011961 19084267 20065188 17049068 17242785 21152245 16818667 19487384 17440819 17893378 18815881 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.92 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.92 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.50 | 16813970 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
9.64 | 16192424 16124888 15700767 16097048 3786805 16011737 16050911 15721981 10355542 16227642 18705752 15673190 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
9.64 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.73 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.42 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.08 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
8.73 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
8.73 | 17173139 6705139 1701930 20935162 20007298 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.73 | 16507464 15276417 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.73 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.73 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.90 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.48 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
7.48 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.48 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.53 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.72 | 11754973 17287366 15728586 11179087 17124262 16170337 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.72 | 16120746 18850075 18670907 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.04 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.52 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.52 | 20056578 19524636 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.16 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.50 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.08 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.81 | 15861022 16919318 11677210 17681005 16105132 17333356 17110522 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.08 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.64 | 15340226 8697196 12621046 16354765 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.64 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.62 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.71 | 14991402 10589399 9664655 16925845 8800419 17551590 9125849 9224671 9142499 9211117 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.71 | 19769572 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.28 | 19031437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.65 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.40 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
3.64 | 2869522 3786805 16227642 15998439 21278145 7120509 7440962 10092053 10915739 19336974 19085960 4309450 15968718 15027814 16177239 9327722 11566570 6884620 3732212 7179309 6623471 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.64 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.69 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.39 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.92 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.62 | 9068938 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
11.25 | 8273558 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.25 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
11.25 | 11698051 15177302 16716910 7812673 9599246 8113982 8273558 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.67 | 18230668 16714409 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.67 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.66 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.66 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.24 | 20544844 17893378 19155303 16202921 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.24 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.94 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.02 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.79 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.84 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.46 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.16 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.93 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.05 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.61 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.61 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
18.10 | 12795759 16239168 15959796 17595544 12631006 61145 16045604 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
18.10 | 19004024 18296743 19551842 17967931 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
18.10 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
18.10 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.18 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.37 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.44 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.10 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
20.44 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
20.44 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
20.44 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
20.44 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.59 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.95 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.51 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.12 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.08 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.87 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.87 | 14991402 9664655 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
10.87 | 16080930 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.25 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.51 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
8.15 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.15 | 12621046 15340226 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.67 | 16863852 16490937 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.08 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.89 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 8697196 18606429 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.14 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.45 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.51 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.48 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.53 | 21332399 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
5.19 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.19 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.00 | 15338365 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.47 | 18502941 12791704 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.72 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.38 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.44 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.44 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
15.41 | 8273558 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
15.41 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
15.41 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
15.41 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
15.41 | 15177302 8273558 11698051 7812673 7562506 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
4.13 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.30 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.30 | 11836018 18457598 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.68 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.66 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.66 | 17551590 15992940 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.55 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.02 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.02 | 12488133 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
2.97 | 18625569 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.73 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.62 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.06 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.09 | 16140955 17294898 17339181 16823087 17712046 19035177 19642359 17361223 17217047 19075265 17107899 9834237 17506722 16891316 19225113 17649720 16788101 16766008 17368321 15748426 17301526 19029980 16331271 16935935 12679006 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.24 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.09 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
10.75 | 11408273 17157831 16943688 21278145 11903743 16239168 17174718 17334410 16221502 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
10.75 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
10.75 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.62 | 17761835 17698563 15730626 12666154 12958196 14620537 12898905 17565644 17805973 18006644 15123356 18054572 12649538 12445418 15673190 17823541 17869086 16015684 17481882 16116963 15362042 14512876 12546737 12389079 14748882 15925388 18339082 15370692 12741479 14716496 17922224 15893842 15931870 18317297 17766677 15650968 18277467 15052691 12632514 18481824 18187930 18166357 15818738 18429990 16136751 18705752 17557913 15057751 18472094 17631135 12586293 18156304 15996030 16027843 18472332 15876570 17714472 16192424 18412020 12632512 18251166 12445421 17708605 17640975 16638106 18420326 18395914 17525996 16248980 12667390 15338365 18418968 18210741 18395095 18376398 12609069 16033810 17976157 11481614 16097048 16011737 17900296 20821823 17944888 18205269 13678700 18279442 10355542 14724832 14716833 18263696 17721639 15959796 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.62 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.62 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.62 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
6.62 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
4.02 | 15830285 16964402 15720792 16246199 17285989 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
4.02 | 19363144 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.08 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.61 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
13.89 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
13.89 | 19482888 19812893 15975961 19073162 8742319 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.89 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
13.89 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.89 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
9.48 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
9.48 | 1399818 2563599 18308698 6150874 17172636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.48 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.24 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
7.24 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
8.43 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.43 | 19931552 16712894 17077188 17306315 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
8.43 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.43 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.43 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
8.43 | 11062179 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.67 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.07 | 19196723 11731420 14580682 16827153 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
6.07 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.47 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.75 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.00 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.00 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.00 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.10 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.34 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.03 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.95 | 12213967 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.39 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.51 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.49 | 19410462 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
8.16 | 16946489 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.16 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.16 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.58 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.92 | 19189210 19196722 19200415 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
15.88 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.88 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.88 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.12 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.12 | 9142499 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.27 | 17217161 16723640 21332399 18457598 19632207 11836018 20518802 20132043 18674790 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.28 | 17016548 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.90 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.79 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.79 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.83 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
8.52 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.52 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.52 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.60 | 11578682 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.21 | 18404319 12065085 18922899 8330346 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.17 | 12520081 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.92 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.47 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.55 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.22 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.22 | 11896295 11222880 11118676 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.12 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.10 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.10 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.10 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.10 | 15084515 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.52 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.23 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.41 | 12752131 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.71 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.70 | 10548101 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.02 | 16283617 16116481 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.63 | 3137016 11442880 16876388 4039156 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.74 | 6407741 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.62 | 7327846 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.42 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.25 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.25 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
13.25 | 8985016 8330346 11807781 12065085 18404319 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.25 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.29 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.29 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.95 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.73 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.79 | 17261132 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.45 | 16517955 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.90 | 16684133 16045194 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.54 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.07 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.82 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
6.97 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
6.97 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.71 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.17 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.00 | 17306315 11723127 16452187 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.00 | 17572228 8653321 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.15 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.15 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.93 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.21 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.53 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.34 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.51 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.46 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.97 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.17 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.66 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.89 | 16287080 |